Chemocentryx Inc. buy dimontalban
Start price
13.07.21
/
80%
€14.10
Target price
13.07.22
€21.00
Performance (%)
-10.78%
End price
13.08.21
€12.58
Summary
This prediction ended on 13.08.21 with a price of €12.58. The price of Chemocentryx Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.78%. dimontalban has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Chemocentryx Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to dimontalban what are the pros and cons of Chemocentryx Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
positive Cash Flow expected
Standard Investments for future growth
Capable Management
Good culture
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Top 10 in its market
Future proof or reliable business model
Cons
Very low/no dividend yield expected
Bad rating
Risky balance sheet
ROE lower than 10% per year
Few uniques
Higher risks for its business
Significant cyclical dependencies
Little known brand
Comments by dimontalban for this prediction
In the thread Chemocentryx Inc. diskutieren
Buy mit Kursziel 21,0